Principal Financial Group
DMK

Principal Financial Group’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Principal Financial Group’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-241
Closed -$10K – 2677
2022
Q1 		$10K Sell
241
-14
-5% -$601 ﹤0.01% 2534
2021
Q4 		$11K Sell
255
-143
-36% -$8.92K ﹤0.01% 2521
2021
Q3 		$27K Sell
398
-65
-14% -$4.76K ﹤0.01% 2560
2021
Q2 		$36K Buy
+463
New +$28.2K ﹤0.01% 2589

Other funds holding DMK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Principal Financial Group's DMK Position: Q2 2022 in Review

Principal Financial Group sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2022, closing a stake of 241 shares — an estimated $10K sold.

Principal Financial Group first reported a position in DMK in Q2 2021 and held it in 4 quarters. The position peaked at $36K in Q2 2021. 45 funds tracked by Wall St. Rank hold DMK as of Q2 2022.

  • Principal Financial Group reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2022 after selling out during the quarter.
  • Principal Financial Group sold 241 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2022, an estimated $10K.
  • Principal Financial Group first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2021 and held it in 4 quarters.
  • Principal Financial Group's DMK Pharmaceuticals Corporation Common Stock position peaked at $36K in Q2 2021.
  • 45 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2022.

Based on Principal Financial Group's 13F filing for Q2 2022, filed 10 Aug 2022.